Switch to:
More From Other Websites
8:06 am Gencor Industries swings to Q4 profit with rev up 79%; backlog up 131% Y/Y Dec 03 2016
Gencor posts 4Q profit Dec 02 2016
Gencor posts 4Q profit Dec 02 2016
Gencor Releases Fourth Quarter and Fiscal Year 2016 Results Dec 02 2016
Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) for Relapsed Multiple Myeloma and... Nov 21 2016
A Value Stock to Profit From Trump's Presidency Nov 11 2016
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their... Nov 11 2016
Articles of Association for Genmab A/S Nov 10 2016
CHMP Issues Positive Opinion Recommending Arzerra® (ofatumumab) in Combination with Fludarabine and... Nov 10 2016
Genmab Announces Phase III Study of Daratumumab in Combination with Carfilzomib in Multiple Myeloma Nov 10 2016
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their... Nov 09 2016
Capital Increase in Genmab as a Result of Employee Warrant Exercise Nov 09 2016
Genmab Announces Financial Results for the First Nine Months of 2016 and Improves 2016 Financial... Nov 02 2016
GENCOR RELEASES SECOND QUARTER FISCAL 2016 RESULTS Oct 26 2016
GENCOR RELEASES THIRD QUARTER FISCAL 2016 RESULTS Oct 26 2016
Articles of Association for Genmab A/S Oct 11 2016
U.S. FDA Grants Priority Review for Daratumumab in Relapsed Multiple Myeloma Oct 07 2016
Grant of Warrants to Genmab Employees Oct 06 2016
Data from Phase III POLLUX Study of Daratumumab Published in The New England Journal of Medicine Oct 05 2016
GENCOR INDUSTRIES INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD... Sep 30 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK